BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2847037)

  • 1. Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis.
    Kato S; Yamashita K; Kim T; Tajiri T; Onda M; Sato S
    Mutat Res; 1988 Nov; 202(1):85-91. PubMed ID: 2847037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C.
    Reddy MV; Randerath K
    Mutat Res; 1987 Jul; 179(1):75-88. PubMed ID: 3110608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mitomycin C-DNA adducts in vivo by 32P-postlabeling: time course for formation and removal of adducts and biochemical modulation.
    Warren AJ; Maccubbin AE; Hamilton JW
    Cancer Res; 1998 Feb; 58(3):453-61. PubMed ID: 9458089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
    Pan SS; Yu F; Hipsher C
    Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of mitomycin C-DNA adducts in human breast cancer cells grown in culture, as xenografted tumors in nude mice, and in biopsies of human breast cancer patient tumors as determined by (32)P-postlabeling.
    Warren AJ; Mustra DJ; Hamilton JW
    Clin Cancer Res; 2001 Apr; 7(4):1033-42. PubMed ID: 11309355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mitomycin C-DNA adduct detection in rat organs and human liver].
    Kato S; Onda M; Tokunaga A; Yoshiyuki T; Matsukura N; Kim DY; Tajiri T; Yamashita K
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1031-7. PubMed ID: 8687217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32P-postlabeling analysis of DNA adducts in rats during estrogen-induced hepatocarcinogenesis and effect of tamoxifen on DNA adduct level.
    Shimomura M; Higashi S; Mizumoto R
    Jpn J Cancer Res; 1992 May; 83(5):438-44. PubMed ID: 1319983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pH on DNA alkylation by enzyme-activated mitomycin C and porfiromycin.
    Yu F; Pan SS
    Mol Pharmacol; 1993 Jun; 43(6):863-9. PubMed ID: 8391116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 32P-postlabeling analysis of DNA adducts in tissues of rats exposed to coke-oven emissions.
    Binková B; Dobiás L; Wolff T; Srám RJ
    Mutat Res; 1994 May; 307(1):355-63. PubMed ID: 7513816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil.
    Fujimoto S; Miyazaki M; Endoh F; Takahashi O; Okui K; Morimoto Y
    Cancer; 1985 Nov; 56(10):2404-10. PubMed ID: 2412682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intra-arterial chemoembolization with albumin microspheres including mitomycin C in inoperable hepatic cancer].
    Endoh F
    Nihon Geka Gakkai Zasshi; 1987 May; 88(5):584-93. PubMed ID: 3037295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison between continuous arterial infusion chemotherapy and mitomycin C microcapsule administration in primary and metastatic liver cancer].
    Itoh J; Nakagawa H; Sasaki H; Takahashi T; Katoh T
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1165-9. PubMed ID: 6307162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in the diagnostic potential of 32P-postlabeling analysis demonstrated by the selective formation and comparative analysis of nitrated-PAH-derived adducts arising from diesel particle extracts.
    Gallagher JE; Kohan MJ; George MH; Lewtas J
    Carcinogenesis; 1991 Sep; 12(9):1685-91. PubMed ID: 1893529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells.
    Dusre L; Covey JM; Collins C; Sinha BK
    Chem Biol Interact; 1989; 71(1):63-78. PubMed ID: 2550152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of hepatocellular carcinoma treated by intrahepatic arterial administration of anticancer agents: serial determination of the concentration of the chemotherapeutic agents in serum and dialysate during hemodialysis].
    Yoshida T; Ohsawa K; Goto T; Chiba S; Nakamura Y; Kondoh K; Sasaki S; Sekine K; Katayama S; Moriai O
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2257-60. PubMed ID: 2173495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
    Randerath E; Avitts TA; Reddy MV; Miller RH; Everson RB; Randerath K
    Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.